Treatment for Cervical Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Markey Cancer Center, Lexington, KYCervical Cancer
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trialtests biomarkers of uterine cervix cancer in women receiving radiochemotherapy and brachytherapy. Blood samples are used to detect cancer markers.

Eligible Conditions
  • Cervical Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Finding Respect and Ending Stigma around HIV (FRESH)
1
EBT-101
1
Behavioral Self-Regulation Skills Counseling + Stigma Management

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 3 months posttherapy

3 months posttherapy
Biomarker

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Finding Respect and Ending Stigma around HIV (FRESH)
1
EBT-101
1
Behavioral Self-Regulation Skills Counseling + Stigma Management

Trial Design

0 Treatment Group

30 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months posttherapy

Who is running the clinical trial?

Charles KunosLead Sponsor
1 Previous Clinical Trials
2 Total Patients Enrolled
Charles Kunos, MD, PhDPrincipal InvestigatorUniversity of Kentucky
2 Previous Clinical Trials
30 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top